Tenon Medical (TNON) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on July 23, 2025, with voting available online, by phone, or by mail.
Stockholders will vote on five key proposals, including director elections, warrant exercisability, equity plan amendments, auditor ratification, and potential adjournment.
The Board recommends voting in favor of all proposals and emphasizes the importance of stockholder participation.
Voting matters and shareholder proposals
Proposals include electing seven directors, approving new warrant exercisability, amending the 2022 Equity Incentive Plan, ratifying the auditor, and authorizing adjournment if needed.
The Board unanimously recommends a “FOR” vote on all proposals.
No other business is expected at the meeting, and no timely stockholder nominations were received.
Board of directors and corporate governance
The Board consists of seven members, four of whom are independent under Nasdaq rules.
Directors are elected annually, and the Board met five times in 2024, with high attendance.
The Nominating and Corporate Governance Committee considers diversity and experience but has no formal diversity policy.
The company maintains a Code of Conduct and makes governance documents available online.
Latest events from Tenon Medical
- Record revenue, margin gains, and new product launches drive growth and improved financials.TNON
Q4 202520 Mar 2026 - Q2 revenue up 21%, gross margin at 52%, but going concern risk remains.TNON
Q2 20241 Feb 2026 - Innovative SI joint fusion tech shows strong results and expands with new miniaturized platform.TNON
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - Q3 revenue fell 6% but gross margin improved; liquidity remains a key concern despite equity raise.TNON
Q3 202414 Jan 2026 - 2024 revenue up 12%, gross margin at 52%, and Catamaran SE launch set for mid-2025.TNON
Q4 202424 Dec 2025 - Registering 5.4M shares for resale after $2.85M raise, with dilution and market risks ahead.TNON
Registration Filing16 Dec 2025 - Annual Meeting to vote on directors, equity plan, preferred stock, and auditor ratification.TNON
Proxy Filing2 Dec 2025 - Annual Meeting to vote on directors, preferred stock, equity plan, auditor, and adjournment.TNON
Proxy Filing2 Dec 2025 - Key 2025 proposals include director elections, warrant approval, equity plan changes, and auditor ratification.TNON
Proxy Filing2 Dec 2025